Literature DB >> 9974166

Apoptosis in early ocular morphogenesis in the mouse.

L K Laemle1, M Puszkarczuk, R N Feinberg.   

Abstract

Development of the eye requires complex interactions between tissues, extracellular matrix and growth factors. Most cells of the optic primordia grow and differentiate into discrete ocular structures; however, other cells have death as their developmental fate. The most common mechanisms of cell death are apoptosis and necrosis. We have identified the cell death that occurs during ocular morphogenesis in ZRDCT-N mice as apoptosis. Mouse embryos, ages E8.5-E11.5, were embedded in paraffin, sectioned at 5 microns and stained with hematoxylin or by the terminal deoxytransferase-mediated dUTP-biotin nick end-labeling (TUNEL) method. The spatial and temporal distribution of apoptotic cells was mapped at 0.5 day intervals using a computerized image analysis system, and 3-D reconstructions were made at each embryonic age. Our data indicate that apoptosis plays a role in normal ocular morphogenesis and provides the groundwork for studies of abnormal ocular development.

Entities:  

Mesh:

Year:  1999        PMID: 9974166     DOI: 10.1016/s0165-3806(98)00153-9

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  15 in total

1.  Lhx2 links the intrinsic and extrinsic factors that control optic cup formation.

Authors:  Sanghee Yun; Yukio Saijoh; Karla E Hirokawa; Daniel Kopinke; L Charles Murtaugh; Edwin S Monuki; Edward M Levine
Journal:  Development       Date:  2009-12       Impact factor: 6.868

2.  Bmp4 mediates apoptotic cell death in the developing chick eye.

Authors:  F Trousse; P Esteve; P Bovolenta
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

3.  Nf2 fine-tunes proliferation and tissue alignment during closure of the optic fissure in the embryonic mouse eye.

Authors:  Wesley R Sun; Sara Ramirez; Kelly E Spiller; Yan Zhao; Sabine Fuhrmann
Journal:  Hum Mol Genet       Date:  2020-12-18       Impact factor: 6.150

4.  In situ analysis of Raidd-beta-galactosidase fusion gene expression in transgenic mouse midgestation embryos.

Authors:  H Motaln; J McWhir; S Horvat
Journal:  Transgenic Res       Date:  2005-02       Impact factor: 2.788

5.  The cellular bases of choroid fissure formation and closure.

Authors:  Cassidy S Bernstein; Mitchell T Anderson; Chintan Gohel; Kayleigh Slater; Jeffrey M Gross; Seema Agarwala
Journal:  Dev Biol       Date:  2018-05-24       Impact factor: 3.582

6.  Multiple requirements of the focal dermal hypoplasia gene porcupine during ocular morphogenesis.

Authors:  Elizabeth J Bankhead; Mary P Colasanto; Kayla M Dyorich; Milan Jamrich; L Charles Murtaugh; Sabine Fuhrmann
Journal:  Am J Pathol       Date:  2014-11-03       Impact factor: 4.307

7.  AP-2alpha knockout mice exhibit optic cup patterning defects and failure of optic stalk morphogenesis.

Authors:  Erin A Bassett; Trevor Williams; Amanda L Zacharias; Philip J Gage; Sabine Fuhrmann; Judith A West-Mays
Journal:  Hum Mol Genet       Date:  2010-02-11       Impact factor: 6.150

8.  HSP110, caspase-3 and -9 expression in physiological apoptosis and apoptosis induced by in vivo embryonic exposition to all-trans retinoic acid or irradiation during early mouse eye development.

Authors:  Julien Gashegu; Reza Ladha; Nathalie Vanmuylder; Catherine Philippson; Françoise Bremer; Marcel Rooze; Stéphane Louryan
Journal:  J Anat       Date:  2007-05       Impact factor: 2.610

9.  Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways.

Authors:  Peter Baluk; Chun Geun Lee; Holger Link; Erin Ator; Amy Haskell; Jack A Elias; Donald M McDonald
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

10.  Investigation of Frizzled-5 during embryonic neural development in mouse.

Authors:  Carole J Burns; Jianmin Zhang; Erinn C Brown; Alyssa M Van Bibber; Johan Van Es; Hans Clevers; Tomo-o Ishikawa; M Mark Taketo; Monica L Vetter; Sabine Fuhrmann
Journal:  Dev Dyn       Date:  2008-06       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.